Interceptive Maxillary Expansion to Relief Anterior Crowding in the Mixed Dentition

July 15, 2025 updated by: Region Örebro County

Interceptive Maxillary Expansion to Relief Anterior Crowding in the Mixed Dentition: a Longitudinal, Randomized Controlled Trial

The goal of this clinical trial is to compare if it is better to treat severe anterior crowding in the early mixed dentition then later in the permanent dentition in children with anterior crowding of the upper teeth. The main questions this trial aims to answer are:

  • If there is a difference in the degree of anterior crowding between the experimental group and the control group after a five year follow-up period.
  • If there is a difference between the experimental group and the control group in regard to oral health related quality of life.
  • If there is spontaneous transversal adaption of the lower dental arch to upper dental arch after maxillary expansion and compare this to the control group.
  • If early maxillary expansion is more cost-effective than treatment in the permanent dentition.

To be eligible for this trial the subject must be children between six and nine years old at the time for inclusion. The children must have crowding of the upper front teeth of six millimeters or more and the lateral incisors should not have erupted or just erupted through the gingiva.

Subjects randomized to the experimental group will get an expansion treatment in the upper jaw with rapid maxillary expansion device to gain enough space for the lateral incisors to erupt. All subjects, also the subjects randomized to the control group, are followed until all permanent teeth have erupted.

At the end of the follow-up period all subjects fill out a questionnaire to evaluate their oral health related quality of life.

Researchers will then compare the subjects in both groups to evaluate if there is a difference in anterior crowding after the follow-up period. Differences in cost-effectiveness, morphological changes and the subjects oral health related quality of life will also be evaluated.

Study Overview

Detailed Description

The study will be conducted on consecutively included subjects referred to the centers and then randomized into either an experimental group or a control group.

To be able to evaluate the amount of anterior crowding before the lateral incisors have erupted, low-dose Cone Beam Computed Tomography-scans are used to measure the width of the unerupted laterals. The anterior crowding is calculated by comparing the width of the laterals with measurements of the distance between the mesial surfaces of the deciduous upper canines on study casts. The eligible subjects are then randomized to either experimental och control group.

The subjects in the experimental group will be treated with a maxillary expansion appliance with bands on the second deciduous molars and arms to the deciduous canines. A small preparation on the palatal surface of the deciduous canines is performed to facilitate bonding of the arms. The screw gives a expansion of 0,20 millimeter per activation. The arms are bonded to the deciduous canines with light curing composite and the bands are cemented on the etched second deciduous molar with glassionomer cement.

Then the subject and the parents are instructed to activate the appliance once a day (1/4 turn) for 2 weeks and thereafter every second day until adequate space for the lateral incisors is obtained and the first permanent molars are approaching scissor-bite.

The expansion can be paused for 7-8 months after 25-30 activations if the lateral incisors are not yet erupted and the permanent molars are going in scissor-bite to allow for their spontaneous correction. The expansion is then continued until adequate space for the lateral permanent incisors is achieved.

During the expansion the subjects will be asked to complete a questionnaire on pain and discomfort.

When enough space is available for the crowding to be resolved the expander is blocked with light curing composite or a stainless steel ligature wire. The appliances is kept as a retainer until the laterals are fully erupted.

After the follow-up period the treatment effects will be evaluated by measuring of the study models. All measurements will be made digitally with the 3Shape OrthoAnalyzer Differences in palatal volume, transversal width of the maxillary and mandibular dentition between the start of the trial and at the end of the follow-up period will be measured. The questionnaires regarding pain and discomfort and PIDAQ will be analyzed.

The last part of the study is to perform a cost-effectiveness analysis for early treatment with maxillary expansion and a cost-effectiveness analysis for treatment in the permanent dentition and then compare them. The direct cost for both experiment and control group will be calculated by adding up material cost and chair-time cost. The indirect cost is defined as the cost for the parents regarding loss of income for the duration of the visits and the trips to and from the clinic. Due to the fact that there are substantial differences in traveling time and income for parents, the indirect costs of treatment will not be taken into account because the randomization will equalize the effect of the differences.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Healthy subjects without sucking habits
  • Permanent maxillary central incisors and first permanent molars fully erupted. DS1M1.
  • No severe crowding or protrusion in the lower arch considering the Leeway space and normal development of the arch.
  • Permanent first molar in normal transversal relation.
  • Crowding of the maxillary incisors with the lateral incisor just erupting ectopically or not yet emerged through the gingiva.
  • Crowding greater than or equal to 6 millimeters between the upper deciduous canines.

Exclusion Criteria:

  • Skeletal asymmetries, anomalies and syndromes.
  • Previous orthodontic treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early maxillary expansion

The subjects in the experimental group will be treated with a maxillary expansion appliance with bands on the second deciduous molars and arms to the deciduous canines. The screw gives a expansion of 0,20 millimeter per activation. The arms are bonded to the deciduous canines with light curing composite and the bands are cemented with glassionomer cement.

The subject are instructed to activate the appliance once a day (1/4 turn) for 2 weeks and thereafter every second day until adequate space for the lateral incisors is obtained.During the expansion the subjects will be asked to complete a questionnaire on pain and discomfort.

The subjects will be recalled for follow-up visits after 24 months (T1), 36 months (T2), 48 months (T3) and when all permanent premolars are erupted (T4).

At T1, T2 and T4 the subjects are asked to fill out the Psychosocial Impact of Dental Aesthetics Questionnaire (PIDAQ).

The subjects need for further treatment will be evaluated and initiated at T4.

The maxillary expansion device is a orthodontic appliance that is used to expand the maxilla in children.
No Intervention: Control group

The control group is not going to receive any treatment under the observation period.

The subjects will be recalled for follow-up visits with photographs (4 extraoral photos and 5 intraoral photos) and study models (digital or cast) after 24 months (T1), 36 months (T2), 48 months (T3) and when all permanent premolars are erupted (T4).

At T1, T2 and T4 the subjects are asked to fill out the Psychosocial Impact of Dental Aesthetics Questionnaire (PIDAQ) to evaluate their oral health related quality of life.

The subjects need for further treatment will be evaluated and initiated at T4.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Long-term spontaneous alignment of anterior maxillary teeth
Time Frame: At the end of the observation period, an average of 5 years
The long-term spontaneous alignment of anterior maxillary teeth will be evaluated visually and measure on the digital study models.
At the end of the observation period, an average of 5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact on oral health related quality of life
Time Frame: At the end of the observation period, an average of 5 years.

The impact of early expansion treatment on the oral health will be measure at the end of the observation period in both the experimental group and the control group. This will be measured with the Psychosocial Impact of Dental Aesthetics Questionnaire (PIDAQ). The PIDAQ is made of four subparts;

  • Dental Self-Confidence; six questions answered on a Likert-scale between 0 and 4. Maximum score is 24 och minimum is zero. Higher score is better.
  • Social Impact: eight questions answered on a Likert-scale between 0 and 4. Maximum score is 32 and zero minimum. Lower score is better.
  • Psychological Impact: six questions answered on a Likert-scale between 0 and 4. Maximum score is 24 and zero minimum. Lower score is better.
  • Aestethic Concern: three questions answered on a Likert-scale between 0 and 4. Maximum score is twelve and zero minimum. Lower score is better
At the end of the observation period, an average of 5 years.
Cost-effectiveness of early expansion treatment
Time Frame: At the end of the observation period, an average of 5 years.
The total cost of treatments in both the control- and experimental group will be compared to evaluate which treatment is the most cost-effective.
At the end of the observation period, an average of 5 years.
Morphological changes in the upper and lower arches.
Time Frame: At the end of the observation period, an average of 5 years.
The morphological changes after expansion will be measured on study models and compared to the study models at the start point. The same will be conducted on the study models for the control group.
At the end of the observation period, an average of 5 years.
Complications of expansion.
Time Frame: At the end of the observation period, an average of 5 years.
This measure will be reported descriptive and the complications analyzed.
At the end of the observation period, an average of 5 years.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 20, 2021

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

January 31, 2028

Study Registration Dates

First Submitted

November 17, 2023

First Submitted That Met QC Criteria

December 29, 2023

First Posted (Actual)

January 2, 2024

Study Record Updates

Last Update Posted (Actual)

July 18, 2025

Last Update Submitted That Met QC Criteria

July 15, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 275470

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Crowding of Anterior Maxillary Teeth

Clinical Trials on Maxillary expansion device

Subscribe